Orphan drug developer Minoryx raises €51...Minoryx Therapeutics SL has closed a €51m financing, including Series C equity financing and complementary bank debt to commercialise X-ALD drug leriglitazone. more ➔
G7 heads call for decarbonisation of indus...G7 Climate, Energy and Environment Ministers have announced a wide range of actions to tackle the triple global crisis of climate change, biodiversity loss and pollution". more ➔
Ellipses Pharma licences SRB22 from SunRoc...Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein set to eliminate solid tumours. more ➔
Evotec signs contracts with Almirall and S...Hamburg-based CRO Evotec SE has inked a drug development partnership with Spanish Almirall SA in dematology. more ➔
Avantium gets EU grant Avantium NV will get a €3m EU funding for a feasibility study of the electrochemical conversion of CO2 to consumer products. more ➔
Enzymaster raises $45m in Series C roundBiocatalysis expert Enzymaster (Germany, China, Singapore) has cashed in $45m to expand its production capacity of engineered biosynthetic enzymes. more ➔
EU starts consultation on novel plant bree...The EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture. more ➔
Evotec and BMS intensify R&D on prote...Hamburg-headquartered Evotec SE has extended and expanded its three-year-old partnership with Bristol Myers Squibb in targeted protein degradation ("molecular glue degraders") for an additional … more ➔
Replacing beef with cellular protein halve...Replacing 20% of global beef consumption with fermentation-derived microbial protein by 2050 could halve annual deforestation and associated carbon dioxide emissions. more ➔
Hot of the press: BIOTECH Insight Newslett...Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG. more ➔
